Legend: 
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”
|
|
|
|
|
341
|
Tue, 8/8/06, 2:00 PM - 3:50 PM
|
CC-609
|
|
QT/QTc - Contributed - Papers
|
Biopharmaceutical Section
|
|
Chair(s): Yun-Ling Xu, U.S. Food and Drug Administration
|
|
2:05 PM
|
Noninferiority Testing in Thorough QT/QTc Studies —  Balakrishna Hosmane, Northern Illinois University; Charles Locke, Abbott Laboratories
|
|
2:20 PM
|
Bias in Estimates of QTc Prolongation by Timepoint-Wise Treatment Comparison — Yibin Wang, Novartis Pharmaceuticals Corporation; Guohua Pan, Johnson & Johnson Pharmaceutical R&D
|
|
2:35 PM
|
Tolerance Regions for Multivariate Random Effects Model with Application to Beat-to-Beat QT-TQ Interval Data — Kimberly Crimin, Pfizer Inc.; Joseph McKean, Western Michigan University
|
|
2:50 PM
|
A New Method for Sample Size Calculation of the Thorough QT/QTc Study — Shu Zhang, Sepracor, Inc.
|
|
3:05 PM
|
Bayesian Measurement Error Approach to QT Interval Correction/Prolongation — Jie Chen, Merck Research Laboratories; Xin Zhao, Merck & Co., Inc.
|
|
3:20 PM
|
Designing and Analyzing Covariate-Adjusted Response Adaptive Randomized Clinical Trials — Ayanbola Ayanlowo, The University of Alabama at Birmingham; David Redden, The University of Alabama at Birmingham
|
|
3:35 PM
|
Floor Discussion
|
| |
